Czechia vs Singapore: Hypertension effective treatment coverage (controlled hypertension)
Czechia
35.5%
in 2019
Singapore
37.6%
in 2019
Czechia rank
13th
Singapore rank
11th
Hypertension effective treatment coverage (controlled hypertension) over time
- Czechia
- Singapore
How they compare
Singapore currently reports 37.6% against 35.5% in Czechia, a difference of 2.1%.
That makes Singapore's figure about 1.1 times Czechia's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Czechia ahead.
Czechia ranks 13th and Singapore ranks 11th of 193 countries.
Across the 3 decades both report, Czechia averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Czechia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 9.8% | 6.6% | 3.1% | Czechia |
| 2000s | 20.1% | 16.4% | 3.8% | Czechia |
| 2010s | 31.2% | 31.5% | 0.3% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Czechia or Singapore?
- Singapore, at 37.6% against 35.5% in Czechia as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Czechia and Singapore?
- 2.1%, with Singapore ahead.
- How many years of comparable data are there for Czechia and Singapore?
- 30 years are reported by both, from 1990 to 2019.
- How do Czechia and Singapore rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Czechia ranks 13th and Singapore ranks 11th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.